What is the recommended dosage and treatment protocol for diloxanide (luminal amoebicide) in a patient with intestinal amoebiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Give Diloxanide in Amoebiasis

Diloxanide furoate should be given at 500 mg orally three times daily for 10 days as a luminal amebicide after completing tissue-active therapy with metronidazole or tinidazole, or as monotherapy for asymptomatic intestinal amoebiasis. 1, 2

Treatment Protocol Based on Clinical Presentation

For Asymptomatic Intestinal Amoebiasis (Cyst Passers)

  • Diloxanide furoate 500 mg orally three times daily for 10 days as monotherapy 1, 3
  • This is the drug of choice for asymptomatic carriage of pathogenic Entamoeba histolytica strains 3
  • Diloxanide achieves high luminal concentrations and has greater efficacy than metronidazole for asymptomatic disease, with parasite clearance rates of 81-96% 4

For Symptomatic Intestinal Amoebiasis or Amoebic Liver Abscess

Two-phase treatment approach is mandatory to prevent relapse:

  1. Initial tissue-active phase:

    • Metronidazole 750 mg orally three times daily for 5-10 days 1, 5
    • Alternative: Tinidazole 2 grams once daily for 3-5 days 2
  2. Follow-up luminal phase (essential):

    • Diloxanide furoate 500 mg orally three times daily for 10 days 1, 2
    • Alternative: Paromomycin 30 mg/kg/day orally in 3 divided doses for 10 days 1

Mechanism and Rationale

Diloxanide works by blocking protein synthesis in E. histolytica trophozoites, preventing their conversion to more virulent cyst forms 4. The ester formulation allows high luminal concentrations, making it particularly effective against intestinal cysts that metronidazole cannot adequately eliminate 4, 3.

Critical pitfall: Failure to provide luminal therapy with diloxanide after metronidazole is the most common cause of treatment relapse 5. Metronidazole alone does not eliminate intestinal cysts, which can lead to recurrent infection 3, 6.

Pediatric Dosing

While the provided evidence focuses primarily on adult dosing, diloxanide can be used in children with appropriate weight-based adjustments 1.

Combination Therapy Option

A fixed-dose combination of diloxanide furoate 500 mg plus metronidazole 400 mg taken three times daily for 5 days has demonstrated 100% parasitic clearance in both amoebiasis and giardiasis 7. However, the standard sequential approach (metronidazole followed by diloxanide) remains the guideline-recommended strategy 1, 5.

Adverse Effects

Diloxanide is very well tolerated 3. Common side effects include flatulence, anorexia, headache, and urticaria, but these are generally mild 4.

Treatment Monitoring

  • Clinical improvement should occur within 48 hours of initiating metronidazole therapy 5
  • For amoebic liver abscess, most patients respond within 72-96 hours 1, 2
  • If no improvement occurs within 2 days, consider alternative diagnoses or drug resistance 1
  • Stool examination should be repeated after completing the full course to confirm parasitic clearance 7

References

Guideline

Treatment of Amoebiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Parasitic Infections with Tinidazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapy of entamebiasis.

Journal of chemotherapy (Florence, Italy), 1989

Guideline

Management of Intestinal Amoebiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Therapy for malaria and amoebiasis].

Immunitat und Infektion, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.